Laboratorios Senosiain, S.A. de C.V.   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Mexico City Mexico (1928)
Status: No NME R&D (1928)

Organization Overview

First Clinical Trial
2008
NCT00760032
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Laboratorios Senosiain, S.A. de C.V.